Dyne Therapeutics, Inc. (DYN)
16.42
-0.28
(-1.71%)
USD |
NASDAQ |
Jan 20, 11:20
Dyne Therapeutics Cash from Investing (Quarterly): -37.96M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | -587.93M |
| Structure Therapeutics, Inc. | -49.46M |
| MannKind Corp. | -25.06M |
| Sarepta Therapeutics, Inc. | 232.40M |
| Denali Therapeutics, Inc. | 57.83M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -90.78M |
| Cash from Financing (Quarterly) | 217.33M |
| Free Cash Flow | -397.01M |
| Free Cash Flow Per Share (Quarterly) | -0.7754 |
| Free Cash Flow to Equity (Quarterly) | -109.35M |
| Free Cash Flow to Firm (Quarterly) | -107.06M |
| Free Cash Flow Yield | -20.67% |